Furthermore, serum S100A4 might be a possible specific biomarker for preoperatively distinguishing CRSwNP endotypes, and contribute to understanding the underlying pathogenesis of Eos CRSwNP. This evidence concerns the gene S100A4 and chronic rhinosinusitis with nasal polyps.